Summary

Amends the

to: provide for prices for medicines supplied under the Pharmaceutical Benefits Scheme (PBS) to be expressed uniformly across different programs based on one ex-manufacturer price for all brands of a pharmaceutical item; provide for this uniform price to be used to set prices for different quantities of a pharmaceutical item and to calculate price changes, patient charges and price disclosure reductions; and make technical amendments in relation to listing PBS medicines for supply only through PBS prescriber bags.